Bloodstream Infections and Antimicrobial Stewardship
BioFire Diagnostics Blog
Featured Expert: Tristan T. Timbrook, PharmD, MBA, BCPS
In this quick-read interview, Dr. Tristan Timbrook details the important role syndromic panels can play in antimicrobial stewardship programs and he addresses the following topics:
- Why molecular rapid diagnostic tests should be the standard of care for patients with bloodstream infections;
- Important considerations when implementing a rapid diagnostic test including the syndromic choice;
- The impact of choosing the comprehensive BioFire BCID Panel over a Gram stain-directed approach.
Dr. Timbrook is a former research assistant professor in the Division of Epidemiology at the University of Utah School of Medicine and antimicrobial stewardship pharmacist at the University of Utah Hospital. Post interview, Dr. Timbrook went on to join the BioFire team as a global medical scientist.
Visit the BioFire blog to read Dr. Timbrook's interview.
Learn more about the BioFire® Blood Culture Identification 2 (BCID2) Panel. 43 Targets. 1 Test. About 1 Hour. BioFire is a bioMérieux company.